Read More

Mostly Tricks, Few Treats For Pot Stocks in 2022

Halloween is prime spooky season, but for most investors, all of 2022 has been quite scary. Stocks across the board have taken substantial hits this year, with cannabis particularly affected. Cannabis' surging pandemic performances have been dashed mostly. Now, Fed uncertainty looms while profitability continues to elude most operators, from MSOs to the ancillary market.


Read More

Cannabis Stocks Chart Of The Week: Will Debt Maturities Trip Up The Big 10 MSOs?

Nine of the ten largest debt raises ever completed for U.S. Cultivation & Retail companies were closed in 2021 and, to a much lesser extent, YTD 2022. Over $3.8B of debt was sold over this period, far more than in any similar period in U.S. Cannabis history. Investors should be paying close attention to the efforts of MSOs to extend or refinance their upcoming debt maturities.